Investigational Site Number :2500003
Pierre-Bénite 69495
0 studies enrolling now · 1 studies all time
What they study most
Plasma Cell Myeloma
Studies at this site
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
— Completed